| SC 13G/A |
Report
|
SPYRE THERAPEUTICS INC. |
Apr 23, 2024 |
|
| SC 13G/A |
Report
|
ASCENDIS PHARMA A/S |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
KRYSTAL BIOTECH, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
AMICUS THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
MADRIGAL PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
MERSANA THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
KYMERA THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
MONTE ROSA THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
XENON PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
| SC 13G |
Report
|
VERRICA PHARMACEUTICALS INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
CYMABAY THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G |
Report
|
SPYRE THERAPEUTICS, INC. |
Feb 14, 2024 |
|
| SC 13G |
Report
|
STRUCTURE THERAPEUTICS INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
UNITED THERAPEUTICS CORPORATION |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
MARINUS PHARMACEUTICALS, INC. |
Feb 14, 2024 |
|
| SC 13G |
Report
|
BIOCRYST PHARMACEUTICALS INC. |
Feb 14, 2024 |
|
| SC 13G/A |
Report
|
IO BIOTECH, INC. |
Feb 14, 2024 |
|
| SC 13G |
Report
|
ASCENDIS PHARMA A/S |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
XENON PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
MONTE ROSA THERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
MERSANA THERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
IVERIC BIO, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
MADRIGAL PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
| SC 13G |
Report
|
KYMERA THERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
MARINUS PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
AMICUS THERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
UNITED THERAPEUTICS CORPORATION |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G |
Report
|
KRYSTAL BIOTECH, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
KURA ONCOLOGY, INC. |
Feb 14, 2023 |
|
| SC 13G |
Report
|
DICE THERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
ADVERUM BIOTECHNOLOGIES, INC. |
Feb 14, 2023 |
|
| SC 13G/A |
Report
|
POINT BIOPHARMA GLOBAL INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
RELMADA THERAPEUTICS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
FENNEC PHARMACEUTICALS INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
ARENA PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
ARENA PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G |
Report
|
MONTE ROSA THERAPEUTICS, INC. |
Feb 11, 2022 |
|
| SC 13G |
Report
|
|
Feb 11, 2022 |
|
| SC 13G |
Report
|
IO BIOTECH, INC. |
Feb 11, 2022 |
|
| SC 13G |
Report
|
APELLIS PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
MADRIGAL PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
CYMABAY THERAPEUTICS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
UNITED THERAPEUTICS CORPORATION |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
ADVERUM BIOTECHNOLOGIES, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
MARINUS PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
XENON PHARMACEUTICALS, INC. |
Feb 11, 2022 |
|
| SC 13G/A |
Report
|
MARINUS PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
XENON PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
KARYOPHARM THERAPEUTICS INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
CUE BIOPHARMA, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
ATHENEX, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
ALIMERA SCIENCES, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
PMV PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
THERAPEUTICS ACQUISITION CORP. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
TRILLIUM THERAPEUTICS INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
KURA ONCOLOGY, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
UNITED THERAPEUTICS CORPORATION |
Feb 12, 2021 |
|
| SC 13G |
Report
|
ARENA PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
AVADEL PHARMACEUTICALS PLC |
Feb 12, 2021 |
|
| SC 13G |
Report
|
MADRIGAL PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
IVERIC BIO, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
RELMADA THERAPEUTICS, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
MERSANA THERAPEUTICS, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
GENOCEA BIOSCIENCES, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
CONSTELLATION PHARMACEUTICALS, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
FENNEC PHARMACEUTICALS INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
ADVERUM BIOTECHNOLOGIES, INC. |
Feb 12, 2021 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Feb 12, 2021 |
|
| SC 13G |
Report
|
CYMABAY THERAPEUTICS, INC. |
Sep 1, 2020 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 24, 2020 |
|
| SC 13G/A |
Report
|
INTEC PHARMA LTD. |
Feb 14, 2020 |
|
| SC 13G |
Report
|
CUE BIOPHARMA, INC. |
Feb 14, 2020 |
|
| SC 13G |
Report
|
KARYOPHARM THERAPEUTICS INC. |
Feb 14, 2020 |
|
| SC 13G |
Report
|
CYMABAY THERAPEUTICS, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
AMICUS THERAPEUTICS, INC. |
Feb 14, 2020 |
|
| SC 13G |
Report
|
CONSTELLATION PHARMACEUTICALS INC |
Feb 14, 2020 |
|
| SC 13G |
Report
|
|
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
BIODELIVERY SCIENCES INTERNATIONAL, INC. |
Feb 14, 2020 |
|
| SC 13G |
Report
|
|
Feb 14, 2020 |
|
| SC 13G |
Report
|
ATHENEX, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
ALIMERA SCIENCES, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
TELIGENT, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
TG THERAPEUTICS, INC. |
Feb 14, 2020 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Jul 25, 2019 |
|
| SC 13G/A |
Report
|
INTEC PHARMA LTD. |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
ALIMERA SCIENCES, INC. |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
TELIGENT, INC. |
Feb 14, 2019 |
|
| SC 13G |
Report
|
XENON PHARMACEUTICALS, INC. |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
FENNEC PHARMACEUTICALS INC. |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
AMICUS THERAPEUTICS, INC. |
Feb 14, 2019 |
|
| SC 13G |
Report
|
TG THERAPEUTICS, INC. |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Feb 14, 2019 |
|
| SC 13G |
Report
|
BIODELIVERY SCIENCES INTERNATIONAL, INC. |
Feb 14, 2019 |
|
| SC 13G |
Report
|
INTEC PHARMA LTD. |
Feb 12, 2018 |
|
| SC 13G/A |
Report
|
ONCOBIOLOGICS, INC. |
Feb 12, 2018 |
|
| SC 13G/A |
Report
|
ALIMERA SCIENCES, INC. |
Feb 12, 2018 |
|
| SC 13G |
Report
|
FENNEC PHARMACEUTICALS INC. |
Feb 12, 2018 |
|
| SC 13G |
Report
|
AMICUS THERAPEUTICS, INC. |
Feb 12, 2018 |
|
| SC 13G |
Report
|
CATALYST BIOSCIENCES, INC. |
Feb 12, 2018 |
|
| SC 13G |
Report
|
TELIGENT, INC. |
Feb 12, 2018 |
|
| SC 13G |
Report
|
|
Feb 12, 2018 |
|
| SC 13G |
Report
|
VIVEVE MEDICAL, INC. |
Feb 12, 2018 |
|
| SC 13G/A |
Report
|
IOVANCE BIOTHERAPEUTICS, INC. |
Feb 12, 2018 |
|
| SC 13G/A |
Report
|
MIRATI THERAPEUTICS, INC. |
Oct 3, 2017 |
|
| SC 13G |
Report
|
VENBIO SELECT ADVISOR LLC |
Feb 9, 2017 |
|
| SC 13G/A |
Report
|
LION BIOTECHNOLOGIES, INC. |
Feb 9, 2017 |
|
| SC 13G/A |
Report
|
|
Feb 9, 2017 |
|
| SC 13G |
Report
|
ALIMERA SCIENCES, INC. |
Feb 9, 2017 |
|
| SC 13G |
Report
|
|
Feb 9, 2017 |
|
| SC 13G |
Report
|
VENBIO SELECT ADVISOR LLC |
Feb 12, 2016 |
|
| SC 13G |
Report
|
VENBIO SELECT ADVISOR LLC |
Feb 12, 2016 |
|
| SC 13G |
Report
|
VENBIO SELECT ADVISOR LLC |
Feb 12, 2016 |
|